Loading company…
VenstraMedical develops a percutaneous ventricular assist device for heart failure care.
Founded in 2018 in New South Wales, Australia, VenstraMedical develops medical devices, including a percutaneous ventricular assist device (pVAD). The device is designed for minimally invasive insertion and circulatory support for people with severe heart failure. CEO Martin Cook and CTO Sukumaran Thambar founded the company. In November 2025, it raised an undisclosed amount of venture funding from Highcroft Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in